Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2024 (3)
  • 2022 (5)
  • 2020 (1)

Subject

  • Drug Trafficking (155)
  • Arrests/Convictions - Major (132)
  • Synthetic drugs (83)
  • Seizures (Drugs/Property) (56)
  • Guns/Weapons (48)
  • Overdose (47)
  • Fake Pills (46)
  • Major Law Enforcement Operation (32)
  • Guilty Plea (28)
  • Take Back Day (23)
  • OCDETF/Task Force (22)
  • Prescription Drugs (22)
  • Outreach/Drug Prevention (18)
  • Pharmaceuticals/Pharmacists/Physicians (17)
  • Money Laundering (12)
  • Extraditions (11)
  • Prevention/Education - DEA websites GSAD, JTT etc (10)
  • Task Forces/Task Force Officers (10)
  • Fentanyl Awareness (7)
  • Counterfeit Pills (5)
  • Public and Media Affairs - also see Congressional Affairs (5)
  • Gangs (4)
  • Press Conferences (4)
  • International/Foreign Operations (3)
  • Narcoterrorism (3)
  • Campaigns (2)
  • Fentanyl Free America (2)
  • HIDTA (2)
  • One Pill Can Kill (2)
  • Red Ribbon (2)
  • Asset Forfeiture (1)
  • Cartel (1)
  • Dark Web- Internet Trafficking (1)
  • El Paso Intelligence Center (1)
  • Intergovernmental Affairs (1)
  • Other (1)
  • Recruitment/Office of Training/Graduations (1)
  • Scam Calls (1)
  • Diversion Division (14)

Drug Name

  • Fentanyl (3)
  • Benzodiazepines (1)
  • Hydromorphone (1)
  • Morphine (1)
  • Opioids (1)
  • Oxycodone (1)

Field Division

  • Atlanta (13)
  • Chicago (18)
  • Dallas (6)
  • Detroit (1)
  • El Paso (11)
  • Houston (17)
  • Los Angeles (4)
  • Louisville (3)
  • Miami (10)
  • New England (36)
  • New Jersey (16)
  • New Orleans (8)
  • New York (27)
  • Omaha (4)
  • Phoenix (4)
  • Rocky Mountain (7)
  • San Diego (3)
  • San Francisco (10)
  • Seattle (25)
  • Sede (11)
  • St. Louis (11)
  • Washington, DC (34)
Clear All Results
14 Results - Showing 1 to 10
PRESS RELEASE

DEA El Paso and United Against Fentanyl will Walk for Lives on July 11

Albuquerque, New Mexico – The U.S. Drug Enforcement Administration El Paso Field Division and United Against Fentanyl (UAF) Rio Rancho Chapter will host a local Walk for Lives 2026 event at Haynes Community Center and Park on July 11, 2026 from 4-6 p.m. in support of DEA’s Fentanyl Free America...
PRESS RELEASE

DEA El Paso and Partners Remove 4,796 Pounds of Unused Medications from Communities in West Texas and New Mexico

El Paso, Texas – DEA and its local law enforcement partners collected 4,796 pounds of unused medications during the 30th National Prescription Drug Take Back Day on April 25, 2026. “I had the pleasure of visiting multiple locations in El Paso and saw the overwhelming response from our community,” said...
PRESS RELEASE

United States Files Civil Complaint Against New Mexico Psychologist Alleging Improper Prescribing of Controlled Substances

Note: View the Civil Complaint ALBUQUERQUE – The United States has filed a civil complaint in federal court alleging that a New Mexico psychologist unlawfully prescribed controlled substances without a legitimate medical purpose, in violation of the Controlled Substances Act. In a complaint filed in federal court, the United States...
PRESS RELEASE

El Paso Man Sentenced to 15 Years in Federal Prison for Deadly Fentanyl Deal

EL PASO, Texas – An El Paso man was sentenced in federal court to 188 months in prison for distribution of fentanyl causing death, announced Omar Arellano, Special Agent in Charge of the DEA's El Paso Division and U.S. Attorney for the Western District of Texas, Justin R. Simmons. According...
PRESS RELEASE

El Paso Doctor Enters $200,000 Settlement Following State and Federal Fraud Allegations

EL PASO, Texas – Dr. Brian August, located in El Paso, has agreed to pay $200,000 to resolve allegations that he violated the Controlled Substances Act, the False Claims Act, and the Texas Health Care Program Fraud Prevention Act. The allegations involved the issuance of 255 controlled substance prescriptions to...
PRESS RELEASE

OptumRx Agrees to Pay $20M to Resolve Allegations that It Filled Opioid Prescriptions in Violation of the Controlled Substances Act

SAN DIEGO – OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act. The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013...
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Enters 15th Year of Removing Unneeded Medications from Communities

El Paso – Together with its law enforcement partners, the Drug Enforcement Administration will host its 26th National Prescription Drug Take Back Day on Saturday, April 27, from 10 a.m. to 2 p.m. This event aims to remove unneeded prescriptions from homes to help prevent medication misuse by offering anonymous...
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
PRESS RELEASE

New Mexico Pharmacy Agrees to Settlement Relating to Violations of the Controlled Substances Act

ALBUQUERQUE, N.M. – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Joe’s Pharmacy of Peralta, New Mexico, has agreed to pay to the United States $50,000 representing civil penalties under the Controlled Substances Act (CSA). The agreement settles civil claims against Joe’s Pharmacy...

Paginación

  • Current page 1
  • Página 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster